JP2021533090A5 - - Google Patents
Info
- Publication number
- JP2021533090A5 JP2021533090A5 JP2021500279A JP2021500279A JP2021533090A5 JP 2021533090 A5 JP2021533090 A5 JP 2021533090A5 JP 2021500279 A JP2021500279 A JP 2021500279A JP 2021500279 A JP2021500279 A JP 2021500279A JP 2021533090 A5 JP2021533090 A5 JP 2021533090A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- alkyl
- cancer
- composition according
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1811364.7A GB201811364D0 (en) | 2018-07-11 | 2018-07-11 | Combination therapy |
| GB1811364.7 | 2018-07-11 | ||
| PCT/EP2019/068287 WO2020011724A1 (en) | 2018-07-11 | 2019-07-08 | Combination therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021533090A JP2021533090A (ja) | 2021-12-02 |
| JP2021533090A5 true JP2021533090A5 (enExample) | 2022-07-19 |
Family
ID=63272970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500279A Pending JP2021533090A (ja) | 2018-07-11 | 2019-07-08 | 併用療法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20230132256A1 (enExample) |
| EP (1) | EP3820478A1 (enExample) |
| JP (1) | JP2021533090A (enExample) |
| KR (1) | KR20210031696A (enExample) |
| CN (1) | CN112367999A (enExample) |
| AU (1) | AU2019301850A1 (enExample) |
| BR (1) | BR112021000456A2 (enExample) |
| CA (1) | CA3101703A1 (enExample) |
| EA (1) | EA202092824A1 (enExample) |
| GB (1) | GB201811364D0 (enExample) |
| IL (1) | IL279908A (enExample) |
| MX (1) | MX2020013446A (enExample) |
| PH (1) | PH12021550035A1 (enExample) |
| SG (1) | SG11202012401RA (enExample) |
| UA (1) | UA126313C2 (enExample) |
| WO (1) | WO2020011724A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202011993D0 (en) | 2020-07-31 | 2020-09-16 | Adc Therapeutics Sa | ANTI-IL 13Ra2 antibodies |
| GB202015916D0 (en) * | 2020-10-07 | 2020-11-18 | Adc Therapeutics Sa | Combination therapy |
| WO2022248268A1 (en) * | 2021-05-28 | 2022-12-01 | Adc Therapeutics Sa | Combination therapy |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| HUT60768A (en) | 1990-03-16 | 1992-10-28 | Sandoz Ag | Process for producing cd25 fixing molecules |
| US7438907B2 (en) | 2002-11-15 | 2008-10-21 | Genmab A/S | Human monoclonal antibodies against CD25 |
| SI1934174T1 (sl) | 2005-10-07 | 2011-08-31 | Exelixis Inc | Inhibitorji MEK in postopki za njihovo uporabo |
| US20140057119A1 (en) * | 2011-02-02 | 2014-02-27 | Pirjo Nissila | Scratch Resistant Gelcoats |
| HRP20190366T1 (hr) * | 2012-10-12 | 2019-04-19 | Medimmune Limited | Pirolobenzodiazepini i njihovi konjugati |
| EP2906296B1 (en) | 2012-10-12 | 2018-03-21 | ADC Therapeutics SA | Pyrrolobenzodiazepine-antibody conjugates |
| ES2680153T3 (es) * | 2012-10-12 | 2018-09-04 | Adc Therapeutics Sa | Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas |
| CN107148285B (zh) | 2014-11-25 | 2022-01-04 | Adc治疗股份有限公司 | 吡咯并苯并二氮杂䓬-抗体缀合物 |
| GB201506405D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| GB201507827D0 (en) * | 2015-05-07 | 2015-06-17 | Adc Therapeutics Sarl | Diagnostic test |
-
2018
- 2018-07-11 GB GBGB1811364.7A patent/GB201811364D0/en not_active Ceased
-
2019
- 2019-07-08 WO PCT/EP2019/068287 patent/WO2020011724A1/en not_active Ceased
- 2019-07-08 EA EA202092824A patent/EA202092824A1/ru unknown
- 2019-07-08 KR KR1020217001943A patent/KR20210031696A/ko not_active Ceased
- 2019-07-08 BR BR112021000456-4A patent/BR112021000456A2/pt not_active Application Discontinuation
- 2019-07-08 CN CN201980045650.9A patent/CN112367999A/zh active Pending
- 2019-07-08 EP EP19742541.6A patent/EP3820478A1/en not_active Withdrawn
- 2019-07-08 JP JP2021500279A patent/JP2021533090A/ja active Pending
- 2019-07-08 UA UAA202008232A patent/UA126313C2/uk unknown
- 2019-07-08 SG SG11202012401RA patent/SG11202012401RA/en unknown
- 2019-07-08 MX MX2020013446A patent/MX2020013446A/es unknown
- 2019-07-08 AU AU2019301850A patent/AU2019301850A1/en not_active Abandoned
- 2019-07-08 US US17/259,466 patent/US20230132256A1/en not_active Abandoned
- 2019-07-08 CA CA3101703A patent/CA3101703A1/en active Pending
-
2020
- 2020-12-31 IL IL279908A patent/IL279908A/en unknown
-
2021
- 2021-01-06 PH PH12021550035A patent/PH12021550035A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021524449A5 (enExample) | ||
| JP2019518741A5 (enExample) | ||
| JP6215429B2 (ja) | Ｃｄ３８を特異的に認識する抗体とシクロホスファミドとを含有する抗腫瘍組合せ | |
| JP6130871B2 (ja) | Ｃｄ３８を特異的に認識する抗体とビンクリスチンとを含有する抗腫瘍組合せ | |
| JP2022017295A5 (enExample) | ||
| JP2018502902A5 (enExample) | ||
| JP2020529863A5 (enExample) | ||
| RU2019138337A (ru) | Конъюгаты на основе антитела, содержащие агонист toll-подобного рецептора, и виды комбинированной терапии | |
| JP2021523159A5 (enExample) | ||
| HRP20171758T1 (hr) | Kombinacija dr5 agonista i anti-pd-1 antagonista i načini primjene | |
| JP2020527332A5 (enExample) | ||
| JP2021533090A5 (enExample) | ||
| JP2019501204A5 (enExample) | ||
| JP2017502994A5 (enExample) | ||
| ES2808565T3 (es) | Composiciones que comprenden anticuerpos anti-CD38 y carfilzomib | |
| JP2018534933A5 (enExample) | ||
| JP2019506403A5 (enExample) | ||
| JP2018516243A5 (enExample) | ||
| JP6557744B2 (ja) | 抗腫瘍剤及び抗腫瘍効果増強剤 | |
| JP2017503000A5 (enExample) | ||
| JP2020506951A5 (enExample) | ||
| JP2017506234A5 (enExample) | ||
| JP2023527962A5 (enExample) | ||
| JP2018511628A5 (enExample) | ||
| JP2022512944A5 (enExample) |